NCT01311349View on ClinicalTrials.gov

Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other Antibiotics

CompletedOBSERVATIONAL

Enrollment

1,575

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

September 30, 2006

Conditions

Infection

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT01311349 - Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other Antibiotics | Biotech Hunter | Biotech Hunter